Source: Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2017 Jan.
Excerpt
The purpose of this Rapid Response report is to summarize the evidence of clinical efficacy for medical marijuana and synthetic cannabinoids in adult populations with PTSD, and identify any evidence-based guidelines for this population.
Copyright © 2017 Canadian Agency for Drugs and Technologies in Health.
Contents
- CONTEXT AND POLICY ISSUES
- RESEARCH QUESTIONS
- KEY FINDINGS
- METHODS
- SUMMARY OF EVIDENCE
- CONCLUSIONS AND IMPLICATIONS FOR DECISION OR POLICY MAKING
- REFERENCES
- APPENDIX 1. Selection of Included Studies
- APPENDIX 2. Characteristics of Included Publications
- APPENDIX 3. Critical Appraisal of Included Publications
- APPENDIX 4. Main Study Findings and Author’s Conclusions
Copyright: This report contains CADTH copyright material and may contain material in which a third party owns copyright. This report may be used for the purposes of research or private study only. It may not be copied, posted on a web site, redistributed by email or stored on an electronic system without the prior written permission of CADTH or applicable copyright owner.
Links: This report may contain links to other information available on the websites of third parties on the Internet. CADTH does not have control over the content of such sites. Use of third party sites is governed by the owners’ own terms and conditions.
Except where otherwise noted, this work is distributed under the terms of a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International licence (CC BY-NC-ND), a copy of which is available at http://creativecommons.org/licenses/by-nc-nd/4.0/